We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

77 hedge funds and large institutions have $103M invested in ChemoCentryx, Inc. in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more call options, than puts

Call options by funds: $551K | Put options by funds: $58K

67% more capital invested

Capital invested by funds: $61.3M → $103M (+$41.2M)

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

8% more funds holding

Funds holding: 7177 (+6)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

21% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 24

Holders
77
Holders Change
+6
Holders Change %
+8.45%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
19
Reduced
24
Closed
17
Calls
$551K
Puts
$58K
Net Calls
+$493K
Net Calls Change
+$633K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$36.7M
WA
2
Wasatch Advisors
Utah
$11.6M +$466K +124,115 +5%
Franklin Resources
3
Franklin Resources
California
$9.72M
BFA
4
BlackRock Fund Advisors
California
$5.21M -$447K -119,075 -9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.86M +$244K +65,013 +6%
AG
6
Artal Group
Luxembourg
$4.04M
SCM
7
Sio Capital Management
New York
$2.89M +$2.41M +642,828 New
OAM
8
Oxford Asset Management
United Kingdom
$2.41M +$2.01M +536,521 New
Bank of America
9
Bank of America
North Carolina
$1.98M +$1.28M +342,106 +346%
NCM
10
Nantahala Capital Management
Connecticut
$1.93M +$1.61M +428,687 New
State Street
11
State Street
Massachusetts
$1.83M -$28.4K -7,563 -2%
BIT
12
BlackRock Institutional Trust
California
$1.55M -$363K -96,835 -22%
Boston Partners
13
Boston Partners
Massachusetts
$1.15M +$960K +255,815 New
Northern Trust
14
Northern Trust
Illinois
$1.02M -$265K -70,535 -24%
BA
15
BlackRock Advisors
Delaware
$923K +$331K +88,325 +75%
Deutsche Bank
16
Deutsche Bank
Germany
$916K +$422K +112,429 +122%
PI
17
Putnam Investments
Massachusetts
$902K
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$871K -$164K -43,790 -18%
CCM
19
Connective Capital Management
California
$861K +$720K +191,881 New
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
$675K +$18.8K +5,008 +3%
IHM
21
Iguana Healthcare Management
New York
$674K +$563K +150,000 New
PAWC
22
P.A.W. Capital
Connecticut
$674K +$563K +150,000 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$664K -$19.8K -5,264 -3%
LCM
24
Landscape Capital Management
New Jersey
$615K +$343K +91,393 +201%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$526K +$83.7K +22,314 +24%

CCXI Hedge Fund Activity: Q2 2016 in Review

77 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2016, worth a combined $103M — up 67% from $61.3M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CCXI positions and 17 closed out — a net gain of 7 holders — while 19 added to existing stakes and 24 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $2.41M. The largest seller was Capital World Investors, exiting entirely with an estimated $3.71M sold.

  • 77 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2016, up from 71 in Q1 2016.
  • Funds reported $103M of ChemoCentryx, Inc. stock for Q2 2016, up 67% quarter-over-quarter.
  • 24 funds opened new ChemoCentryx, Inc. positions in Q2 2016 and 17 closed out, a net change of +7 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2016 was Sio Capital Management, an estimated $2.41M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2016 was Capital World Investors, an estimated $3.71M sold.

Based on aggregated 13F filings for Q2 2016.